unique technology that produces highly effective cell culture media from donated blood
PL BioScience has raised €7.8M across 1 funding round from 6 investors, most recently a round in Aug 2024. Based in Aachen, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-08-12 | Other | €7.8M |
| AVANT BIO,b.value,better ventures,Brightlands Venture Partners,LePure Biotech,TechVision Fonds |
| View deal → |
